Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,576 | 1,550 | 8,404 | 2,208 | 259 |
| Marketable Securities | 758 | 3,372 | 1 | 66,938 | 67,092 |
| Receivables | 17,710 | 18,196 | 15,569 | 218 | 158 |
| Inventories | 1,782 | 1,764 | 1,550 | N/A | N/A |
| Other current assets | 0 | 3,000 | 3,000 | 3,238 | 3,000 |
| TOTAL | $25,038 | $29,149 | $32,897 | $72,659 | $70,530 |
| Non-Current Assets | |||||
| PPE Net | 7,711 | 8,185 | 7,337 | N/A | N/A |
| Investments And Advances | 2,276 | 1,764 | 1,688 | 0 | 0 |
| Intangibles | 17,484 | 17,484 | 17,484 | 0 | 0 |
| Other Non-Current Assets | 8,235 | 9,222 | 8,221 | 4,795 | 1,128 |
| TOTAL | $35,706 | $36,654 | $34,731 | $4,795 | $1,128 |
| Total Assets | $60,744 | $65,803 | $67,627 | $77,453 | $71,657 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,859 | 7,772 | 5,635 | N/A | N/A |
| Accounts payable and accrued liabilities | 5,958 | 5,289 | 3,102 | 1,769 | 1,769 |
| Accrued Expenses | 415 | 820 | 1,368 | 852 | 458 |
| Other current liabilities | 2,304 | 4,013 | 4,220 | N/A | N/A |
| TOTAL | $15,648 | $20,966 | $17,384 | $11,845 | $5,924 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,533 | 1,456 | 1,213 | N/A | N/A |
| Deferred Revenues | N/A | N/A | N/A | 282 | 210 |
| Other Non-Current Liabilities | 16,181 | 16,842 | 21,096 | 12,763 | 12,763 |
| TOTAL | $18,365 | $18,968 | $22,917 | $12,763 | $12,763 |
| Total Liabilities | $34,013 | $39,934 | $40,301 | $24,608 | $18,686 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 878 | 857 | 857 | 1,397 | 1,397 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -2,782 | -2,854 | -4,141 | N/A | N/A |
| Other shareholders' equity | -3,377 | -2,748 | -4 | 996 | 1,122 |
| TOTAL | $26,731 | $25,869 | $27,326 | $52,846 | $52,971 |
| Total Liabilities And Equity | $60,744 | $65,803 | $67,627 | $77,453 | $71,657 |